Rana Atique Anwer, Sajid Ghafor, Huma Ahmad, “Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer”, Pakistan Journal of Medical & Health Sciences, vol. 16, no. 08, p. 356, Sep. 2022.